Talk: Steve McKnight
Tuesday, May 8, 2012 from 4:00 PM to 5:00 PM (CDT)
Special Seminar by Dr. Steve McKnight, UT Southwestern Medical Center
The CCTS is proud to announce co-sponsorship of a talk by Dr. Steve McKnight, Distinguished Chair in Basic Biomedical Research and Sam G. Winstead and F. Andrew Bell Distinguished Chair in Biochemistry at UT Southwestern Medical Center in Dallas, TX. The event is cosponsored by the Department of Genetics, the Department of Biochemistry & Molecular Genetics, the Department of Microbiology, and the CCTS.
His talk will focus on new mechanisms for regulating gene expression through modulation of macromolecular complexes of RNAs called RNA Granules. The title of the seminar will be:
“Reversible Polymerization of Low Complexity Sequences as an Organizational Principle for the Formation of RNA Granules in Eukaryotic Cells”
Dr. McKnight is a distinguished scientist with a long history of major contributions in the areas of intracellular signaling and gene expression, with a special focus on mechanisms of neurogenesis. He is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. He was one of two founding members of Tularik, a biotechnology company that is now a subsidiary of Amgen, devoted to the discovery of ethical drugs that treat disease by regulating gene expression.
When & Where
UAB Center for Clinical and Translational Science (CCTS)
The CCTS accelerates research for improved human health. Led by:
Robert P. Kimberly, M.D.
Howard L. Holley Professor of Medicine
Director, UAB Center for Clinical and Translational Science
Senior Associate Dean for Clinical and Translational Research, UAB School of Medicine
Associate Vice President for Medicine and Biomedical Research
CCTS funding is provided by the NIH National Center for Advancing Translational Sciences grant UL1 TR000165.